Security key
61559X104
MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)
CUSIP: 61559X104
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Class A ordinary share, par value $0.0001 per share
- Total 13F shares
- 36,470,008
- Total 13F value
- $190,106,000
- Share change
- +35,816,136
- SEC-reported price per share
- $5.25
- Number of holders
- 22
- Value change
- +$182,848,000
- Number of buys
- 22
- Number of sells
- 1
- Shares outstanding
- 81,224,792
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
22
Top holders
10
MLTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
MoonLake Immunotherapeutics SEC filings
MoonLake Immunotherapeutics company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61559X104
Recent filing periods:
Ownership snapshot
Top reported holders of MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MARSHALL WACE, LLP
Disclosed value leader
Helix Holdings LLC
Comparable rows
1/2
Latest evidence
05 Apr 2022
13F
3/4/5
Lead comparable stake: 0.81%
1 rows are not safely comparable across share classes.
Quick read
MARSHALL WACE, LLP leads the comparable SEC ownership view at 0.81%.
1 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MARSHALL WACE, LLP's linked filing trail.
Comparable ownership
Top 1
MARSHALL WACE, LLP
0.81%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13F
Company
|
0.81%
|
$7,258,000
653,872 shares
|
— | 31 Mar 2022 |
| Helix Holdings LLC |
3/4/5
Former 10% Holder
|
—
class O/S missing
|
$192,569,820
3,215,000 shares
|
— | 05 Apr 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
36,470,008
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
1
Q2 2022 holders
22
Holder diff
21
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend